This protocol is judged by an institutional assessment board, an impartial team that reviews any clinical trials involving humans. If a research includes a Schedule I drug, when the board approves the protocol as moral, the researchers have to make an application for an investigational new drug (IND) number from your FDA.When beneath the influence